1-2 of 2
Pawel Kurczab, MD
Close
Sort by
Journal Articles

Bendamustine, Gemcitabine and Dexamethasone Chemotherapy Is Effective Salvage and Stem-Cell Mobilization Regimen in Patients with Relapsed or Refractory Hodgkin Lymphoma — Early Results of the Polish Lymphoma Research Group Study

Ewa Paszkiewicz-Kozik, Jan Zaucha, MD PhD, Agata Tyczyńska, MD, Marcin Szymanski, MD, Lukasz Targonski, MD, Joanna Drozd-Sokolowska, MD PhD, Elżbieta Wojciechowska-Lampka, MD, Joanna Tajer, MD PhD, Pawel Kurczab, MD, Joanna Romejko-Jarosinska, MD PhD, Michal Osowiecki, MD, Jan Walewski, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4098.
https://doi.org/10.1182/blood.V130.Suppl_1.4098.4098
Published: 2017
Journal Articles

The Prognostic Role of Interim PET after First Chemotherapy Cycle and PET Sequential Evaluation of Response to ABVD in Hodgkin Lymphoma Patients - the Polish Lymphoma Research Group (PLRG) Observational Study

Jan M Zaucha, MD PhD, Bogdan Malkowski, MD, Edyta Subocz, MD, Stephane Chauvie, PhD, Joanna Tajer, MD, Waldemar Kulikowski, MD, Agnieszka Fijolek-Warszewska, MD, Alberto Biggi, MD, Federico Fallanca, MD, Malgorzata Kobylecka, MD, Miroslaw Dziuk, MD PhD, Dariusz Woszczyk, MD, Justyna Rybka, MD, Renata Kroll-Balcerzak, MD, Fabrizio Bergesio, PhD, Agnieszka Romanowicz, MD, Agnieszka Chamier-Cieminska, MD, Pawel Kurczab, MD, Agnieszka Giza, Krzysztof Lesniewski-Kmak, MD, Wanda Knopinska-Posluszny, MD PhD, Jan Walewski, MDPhDProf, Andrea Gallamini, MD
Journal: Blood
Blood (2015) 126 (23): 3943.
https://doi.org/10.1182/blood.V126.23.3943.3943
Published: 2015